Drug data last refreshed 11h ago · AI intelligence enriched 3d ago
HYDROCORTONE is a corticosteroid injection containing hydrocortisone sodium phosphate, a rapid-acting glucocorticoid used for systemic anti-inflammatory and immunosuppressive effects. It is administered intravenously or intramuscularly for acute inflammatory and allergic conditions, adrenal insufficiency, and shock. The drug works by suppressing the immune response and reducing inflammation across multiple organ systems.
As an older injectable corticosteroid approaching loss of exclusivity, the brand team is likely focused on defending market share against generics and managing decline rather than driving growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on HYDROCORTONE offers limited growth opportunity but valuable experience in mature product management, generic defense, and healthcare economics in a commoditized category. Roles focus on operational efficiency, pricing strategy, and channel management rather than innovation or expansion.
Worked on HYDROCORTONE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo